Home › Markets › Industrials › AMTX

Aemetis Inc. (DE) (AMTX)

AMTX trades on Nasdaq in Industrials, Major Chemicals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$1.56
-2.50% on the day
Market cap
$112.6M
Micro cap
Revenue · 2025
$197.6M
Prior year not contiguous
Net income · 2025
-$77.0M
-39.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/738214/000143774926008289/0001437749-26-008289-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), period ending 2025-12-31.

Profile

FieldValue
TickerAMTX on Nasdaq
SectorIndustrials
IndustryMajor Chemicals
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000738214
SEC industry codeIndustrial Organic Chemicals
Incorporated inNV

Financials · 2025

LineValue
Revenue$197.6M
Net income-$77.0M
Operating income-$37.2M
Net margin-39.0%
Operating margin-18.8%
Revenue growthNo prior-year revenue to compare
Cash$4.9M
Total assets$259.8M
P/E (computed)Net income was not positive
P/S (computed)0.6×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM 424B5
424B52025-02-12
Latest annual report
FORM 10-K
10-K2026-03-16
Latest quarterly / interim
FORM 10-Q
10-Q2026-08-06
Latest current report
FORM 8-K
8-K2026-08-06
Latest proxy
FORM DEF 14A
DEF 14A2026-04-07

Source: SEC EDGAR submissions feed, 856 recent filings. All filings on EDGAR.

Peers in Major Chemicals

TickerCompanyPriceDayMarket cap
ACNTAscent Industries Co.$13.54-0.07%$122.0M
SAFXXCF Global Inc.$0.2939-5.32%$122.1M
CDXSCodexis Inc.$1.32-6.38%$144.5M
ARQArq Inc.$1.97+0.51%$86.0M
LODEComstock Inc.$2.12-0.47%$161.1M
FSIFlexible Solutions International Inc. Common Stock (CDA)$6.08-0.49%$77.7M
LNZALanzaTech Global Inc.$5.48-10.16%$71.7M
CITRCitroTech Inc.$2.78-2.80%$63.2M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier